ClinConnect ClinConnect Logo
Search / Trial NCT06502626

Effects of Sprint Interval Training on Field Hockey Players.

Launched by RIPHAH INTERNATIONAL UNIVERSITY · Jul 15, 2024

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is studying how "Sprint Interval Training," a type of exercise that involves short bursts of intense activity followed by rest or lighter exercise, can improve the running performance, speed, and ability to change direction in field hockey players. This training method has been shown to help athletes perform better, and the researchers want to see how it specifically affects players in this sport.

To participate in the study, individuals need to be between 18 and 30 years old, both male and female, and should have been playing field hockey for at least two years while training moderately (around three hours a week). Participants will undergo a series of exercises as part of the training program and will be monitored for their progress. It's important to note that those with certain health conditions, like heart problems or severe respiratory issues, or any ongoing injuries, will not be eligible to join. This study not only aims to enhance training methods for field hockey players but also seeks to provide valuable insights into improving athletic performance.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Age 18-30 years.
  • Both males and females.
  • Moderate level of training (Approximately 3 hours per week of activity).
  • Playing experience of minimum 2 years.
  • Being physically active in a self-reported manner (Approximately 150 minutes of physical activity weekly).
  • Exclusion Criteria:
  • Systemic Conditions (unstable angina, systemic arterial hypertension, chronic obstructive pulmonary disease, diabetes mellitus, neoplasm, renal failure and sequelae of stroke).
  • Any musculoskeletal issues that made it difficult to follow protocols or conduct testing.

About Riphah International University

Riphah International University is a leading educational institution based in Pakistan, dedicated to advancing healthcare and medical research through innovative clinical trials. With a commitment to excellence in research and education, Riphah emphasizes ethical standards and scientific integrity in its clinical studies. The university collaborates with various stakeholders, including healthcare professionals and industry partners, to enhance patient outcomes and contribute to the global body of medical knowledge. Through its robust research programs, Riphah International University aims to foster a culture of inquiry and improve healthcare delivery both locally and internationally.

Locations

Lahore, Punjab, Pakistan

Patients applied

0 patients applied

Trial Officials

Amna Shahid, T-DPT

Principal Investigator

Riphah International University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported